Table 2.
Parameter (Ref. Range) | Form 1–0 wk | Form 1–2 wk | Form 2–0 wk | Form 2–2 wk | Form 3–0 wk | Form 3–2 wk |
---|---|---|---|---|---|---|
ALP (8–114 U/L) | 39 ± 3 | 46 ± 5 | 37 ± 4 | 40 ± 4 | 32 ± 4 | 35 ± 5 |
ALT (18–64 U/L) | 25 ± 1 | 23 ± 1 | 26 ± 2 | 25 ± 2 | 26 ± 3 | 29 ± 4 |
AST (15–52 U/L) | 27 ± 2 | 24 ± 1 | 25 ± 2 | 23 ± 1 | 24 ± 2 | 26 ± 2 |
Albumin (2.9–3.8 g/dL) | 3.1 ± 0.5 | 3.1 ± 0.3 | 3.1 ± 0.1 | 3.0 ± 0.1 | 3.3 ± 0.1 | 3.4 ± 0.1 |
Total Bilirubin (0.1–0.4 mg/dL) | 0.2 ± 0.1 | 0.2 ± 0.1 | 0.2 ± 0.0 | 0.2 ± 0.0 | 0.2 ± 0.0 | 0.2 ± 0.0 |
Cholesterol (124–334 mg/dL) | 210 ± 10 | 250 ± 29 | 199 ± 22 | 223 ± 19 | 211 ± 20 | 226 ± 19 |
Glucose (79–120 mg/dL) | 91 ± 4 | 105 ± 6 | 100 ± 3 | 89 ± 6 | 102 ± 2 | 91 ± 9 |
ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
No significant differences were noted between time points for any treatment group.